NYSE •
Healthcare •
Diagnostics & Research •
Quote as of 05/08/2026 10:50
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNYSE
Market Capitalization8,707.38 mln
Float47.61 mln
Earnings Date08/12/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.86
Likely reliable
1-Year Forecast
199
Modest upside
Relative Strength
85
/ 100
Strongly outperforming
Debt / Equity
0.81
Moderate leverage
Pre-Tax Margin
9.99%
Moderate margin
Business Description
Charles River Laboratories International is a global life sciences company that supports the development of new medicines by providing research animals, laboratory testing, and drug safety evaluation services to pharmaceutical and biotechnology clients. Founded in 1947 and based in Wilmington, Massachusetts, the company operates across North America, Europe, and the Asia Pacific region. Its work spans the full early-stage drug development process, from initial discovery through preclinical testing and quality control manufacturing support.
